MAP3K14 and depressive symptom measurement: We detected significant reductions in hs‐CRP levels (intervention group: change = −0.56 ± 1.29, p = 0.01; control group: change = −0.81 ± 1.16, p < 0.001) and depression scores (intervention group: change = −1.33 ± 3.66, p = 0.04; control group: change = −1.44 ± 2.83, p = 0.01).